As Massachusetts voters head to the polls tomorrow to decide whether to legalize psychedelics for therapeutic use, a recent study showed that a majority of Americans support psilocybin for mental health treatments. In one of the largest psychedelics-related academic surveys this year, which polled 795 adults nationwide, about 85% approved of supervised psilocybin use in […]
By Jodi Green, Karina Bashir and Matt Brockmeier of Antithesis Law *** The psychedelic ecosystem stands at a critical juncture as businesses and advocates navigate complex legal landscapes. Although the federal pathway for psychedelics faces significant hurdles, states are stepping up to create innovative frameworks for access. This article will explore developments at both the […]
The following article is a recap of topics discussed during our Oct. 16 webinar on expanding access to psychedelic therapy with expert panelists Sherry Rais, CEO of Enthea and Kat Thompson, CEO of Fractal Soul Service Center, and moderated by Solome Tibebu, CEO of Behavioral Health Tech. Behavioral Health Tech is the largest community dedicated […]
Legal psychedelic-assisted therapy is one step closer to becoming a reality in the Garden State. New Jersey’s Psilocybin Behavioral Health Access and Services Act was approved Monday by the state’s Senate Budget Committee. The bill, which was previously approved by the Senate Health Committee, now advances to the 2nd Reading in the Senate — and […]
Lawmakers in New Hampshire voted against a bill Wednesday that that would have established a state-regulated therapeutic psychedelic program to treat specific mental health conditions, saying the measure was “far too broad.” House Bill 1693 would have established “alternative treatment centers” where patients could consume psilocybin, mescaline or LSD to treat disorders such as depression, […]